Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239

Journal of Virology

Volumn 71, Issue 3, 1997, Pages 1911-1921

  Miller, Christopher J ^a,b   McChesney, Michael B ^a   Lü, Xusheng ^a   Dailey, Peter J ^c   Chutkowski, Christine ^d   Lu, Ding ^a   Brosio, Paul ^a   Roberts, Bryan ^d   Lu, Yichen ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d Virus Research Institute Inc Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEXUALLY TRANSMITTED DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS ENVELOPE; VIRUS GENE; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 0031046895     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.3.1911-1921.1997     Document Type: Article

References (45)

1. Ahmed, S., B. Lohman, M. Marthas, L. Giavedoni, Z. El-Amad, N. L. Haigwood, C. J. Scandella, M. B. Gardner, P. A. Luciw, and T. Yilma. 1994. Reduced viral load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10:195-204.
2. Archibald, D. W., D. J. Witt, D. E. Craven, M. W. Vogt, M. S. Hirsch, and M. Essex. 1987. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J. Infect. Dis. 156:240-241.
3. Belec, L., A. Georges, G. Steenman, and P. Martin. 1989. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J. Infect. Dis. 160:385-391.
4. Belec, L., C. Tevi-Benissan, G. Gresenguet, D. Meillet, and J. Pillot. 1994. HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet 343:1047-1048.
5. Bogers, W. M. J. M., H. Niphius, P. ten Hafft, J. D. Laman, W. Koornstra, and J. L. Heeney. 1995. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 9:F13-F18.
6. Chakrabarti, L., M. Guyader, M. Alizon, M. D. Daniel, R. C. Desrosiers, P. Tiollais, and P. Sonigo. 1987. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 328:543-547.
7. Coliman, R., J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An Infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol. 66:7517-7521.
8. Dailey, P. J., M. Zamroud, R. Kelso, J. Kolberg, and M. Urdea. 1995. Quantitation of simian immunodeficiency virus (SIV) RNA in plasma of acute and chronically infected rhesus macaques using a branched DNA (bDNA) signal amplification assay, abstr. 99, p. 180. In Abstracts of the 13th Annual Symposium on Nonhuman Primate Models of AIDS.
9. Galetto-Lacour, A., S. Yerly, T. V. Perneger, C. Baumberger, B. Hirschel, and L. Perrin. 1996. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. J. Infect. Dis. 173:1388-1393.
10. Heeney, J. L., L. Holterman, P. ten Hafft, R. Dubbes, W. Koornstra, V. Teeuwsen, P. Bourquin, S. Norley, and H. Niphuis. 1994. Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge. AIDS Res. Hum. Retroviruses. 10(Suppl.):S117-S121.
11. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carrol, L. C. Yang, S. Goldstein, M. J. Piatak, W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
12. Hoxie, J. A., B. S. Haggarty, S. E. Bonser, J. L. Rackowski, H. Shan, and P. J. Kanki. 1988. Biological characterization of a simian immunodeficiency virus-like retrovirus (HTLV-IV): evidence for CD4-associated molecules required for infection. J. Virol. 62:2557-2568.
13. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, and R. Desrosiers. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
14. Letvin, N. L., J. Li, M. Halloran, M. P. Cranage, E. W. Rud, and J. Sodroski. 1995. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69:4569-4571.
15. Lohman, B., J. Higgins, M. Marthas, P. Marx, and N. Pedersen. 1991. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29: 2187-2192.
16. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. A. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates to resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
17. Lohman, B. L., C. J. Miller, and M. B. McChesney. 1995. Antiviral cytotoxic T lymphocytes in the vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:5855-5860.
18. Lu, X. S., L. Belec, and J. Pillot. 1993. Anti-gp 160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J. Infect. Dis. 167: 1189-1192.
19. Lu, Y., B. Brosio, M. Lafaile, J. Li, R. G. Collman, J. Sodroski, and C. J. Miller. 1996. Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques. J. Virol. 70:3045-3050.
20. Marthas, M., S. Sutjipto, C. Miller, J. Higgins, J. Torten, R. Unger, H. Kiyono, J. McGhee, P. Marx, and N. Pedersen. 1992. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge, p. 117-122. In F. Brown, R. M. Chanock, H. S. Ginsberg, and R. A. Lerner (ed.), Vaccines 1992. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
21. Marthas, M. L., B. Banapour, S. Sutjipto, M. E. Siegel, P. A. Marx, M. B. Gardner, N. C. Pedersen, and P. A. Luciw. 1989. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18:311-319.
22. Marthas, M. L., C. J. Miller, S. Sutjipto, J. Higgins, J. Torten, B. L. Lohman, R. E. Unger, H. Kiyono, J. R. McGhee, P. A. Marx, and N. C. Pedersen. 1992. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J. Med. Primatol. 21:99-107.
23. mac. J. Virol. 67:6047-6055.
24. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamschikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
25. Mellors, J. W., C. R. J. Rinaldo, P. Gupta, W. R.M., J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
26. Miller, C., D. Kang, M. Marthas, Z. Moldoveanu, H. Kiyono, P. Marx, J. Eldridge, J. Mestecky, and J. McGhee. 1992. Genital secretory immune response to chronic SIV infection: a comparison between intravenously and genitally inoculated rhesus macaques. Clin. Exp. Immunol. 88:520-526.
27. Miller, C. J. 1994. Mucosal transmission of SIV. Curr. Top. Microbiol. Immunol. 188:107-122.
28. Miller, C. J., N. J. Alexander, P. Vogel, J. Anderson, and P. A. Marx. 1992. Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21:64-68.
29. Miller, C. J., N. J. Alexander, S. Sutjipto, A. G. Hendrickx, M. Jennings, and P. A. Marx. 1990. Effect of virus dose and nonoxynol-9 on the genital transmission of SIV in rhesus macaques. J Med Primatol. 19:401-409.
30. Miller, C. J., N. J. Alexander, S. Sutjipto, A. A. Lackner, A. G. Hendrickx, A. Gettie, L. J. Lowenstine, M. Jennings, and P. A. Marx. 1989. Genital mucosal transmission of simian immunodeficiency virus: animal model for heterosexual transmission of human immunodeficiency virus. J. Virol. 63:4277-4284.
31. Miller, C. J., and M. B. Gardner. 1991. AIDS and mucosal immunity: usefulness of the SIV macaque model of genital mucosal transmission. J. Acquired Immune Defic. Syndr. 4:1169-1172.
32. Miller, C. J., and Y. Lu. Unpublished data.
33. Miller, C. J., and M. Marthas. Unpublished data.
34. Miller, C. J., M. Marthas, J. Torten, N. J. Alexander, J. P. Moore, G. F. Doncel, and A. G. Hendrickx. 1994. Intravaginal inoculation of rhesus macaques with cell-tree simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
35. Miller, C. J., J. R. McGhee, and M. B. Gardner. 1993. Mucosal immunity, HIV transmission and AIDS. Lab. Invest. 68:129-145.
36. Miller, C. J., P. Vogel, N. J. Alexander, S. Sutjipto, A. G. Hendrickx, and P. A. Marx. 1992. Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am. J. Pathol. 141:655-660.
37. Moore, J. P., Y. Cao, J. Leu, L. Qin, B. Korber, and D. D. Ho. 1996. Inter-and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70:427-444.
38. O'Brien, T. R., W. A. Blattner, D. Waters, M. E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, and J. J. Goedert. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study. JAMA 276:105-110.
39. Pachl, C., J. A. Todd, D. G. Kern, P. J. Sheridan, S.-J. Fong, M. Stempien, B. Hoo, D. Besemer, T. Yeghiazarian, B. Irvine, J. Kolberg, R. Kokka, P. Neuwald, and M. S. Urdea. 1995. Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acquired Immune Defic. Syndr. Hum. Retrovirology 8:446-454.
40. Putkonen, P., L. Walther, Y. J. Zhang, S. Ling, C. Nilsson, J. Albert, P. Biberfeld, R. Thorstensson, and G. Biberfeld. 1995. Long-term protection against SIV-induced disease in macaques vaccinated with a live-attenuated HIV-2 vaccine. Nat. Med. 1:914-918.
41. Sutjipto, S., N. C. Pedersen, C. J. Miller, M. B. Gardner, C. V. Hanson, A. Gettie, M. Jennings, J. Higgins, and P. A. Marx. 1990. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J. Virol. 64:2290-2297.
42. Travers, K., S. Mboup, R. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J. L. Sanka, C. Mullins, I. Ndoye, C. C. Hsie, M. Essex, and P. Kanki. 1995. Natural protection from HIV-1 infection provided by HIV-2. Science 268:1612-1615.
43. Unger, R. E., M. L. Marthas, A. A. Lackner, E. Pratt-Lowe, B. L. Lohman, K. Van Rompay, and P. A. Luciw. 1992. Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J. Med. Primatol. 21:74-81.
44. Wigzell, H. 1991. Prospects for an HIV vaccine. FASEB J. 5:2406-2411.
45. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3714-3733.